A5049119658- Pregnancy and Medication Impact
- Reproductive System and Pregnancy
- COVID-19 Impact on Reproduction
- Maternal and fetal healthcare
- Maternal and Perinatal Health Interventions
- Sarcoidosis and Beryllium Toxicity Research
- Autoimmune and Inflammatory Disorders Research
- Maternal Mental Health During Pregnancy and Postpartum
- Endometriosis Research and Treatment
- Assisted Reproductive Technology and Twin Pregnancy
- Reproductive Biology and Fertility
- Ovarian function and disorders
- Pregnancy-related medical research
- Emergency and Acute Care Studies
- Pregnancy and preeclampsia studies
- Global Maternal and Child Health
- Eosinophilic Esophagitis
Karolinska Institutet
2019-2025
Danderyds sjukhus
2020
Karolinska University Hospital
2017
Center for Clinical Research Dalarna
2001
Abstract Introduction The Stockholm region was the first area in Sweden to be hit by pandemic caused severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). national guidelines on care of women with a positive test for SARS‐CoV‐2 (detection polymerase chain reaction [PCR]) recommend individualized antenatal care, mode delivery based obstetric considerations, and no routine separation mother newborn. Breastfeeding is encouraged, although there specific recommendation regarding wearing...
Monitoring labor and childbirth, early recognition, treatment of complications are critical for preventing adverse birth outcomes. However excessive use interventions during has not been demonstrated to enhance subsequent outcomes may, in fact, pose a risk harm. The World Health Organization recently synthesized research from the last decade concerning progress patient-centered care into new recommendation: Labour Care Guide (LCG). No trial has, however, compared LCG with standard regarding...
Reports on pregnancy outcomes among women with juvenile onset arthritis (JIA) have been few and small. The aim of this study was to assess in a large contemporary cohort diagnosed JIA.In nationwide Swedish population-based between 1992 2011, we identified 1807 births JIA 1 949 202 control births. Since is heterogenic condition, divided into paediatric only (n=1169) persisting adulthood (n=638). ORs 95% CIs were estimated generalised estimating equations.Women at increased risk preterm birth,...
Objective Studies on pregnancy outcomes in psoriatic arthritis (PsA) are scarce and typically of small size. Available studies have reported conflicting results. The aim this study was to describe maternal infant among women with PsA compared without PsA. Design Nationwide cohort study. Setting Swedish registers. Population A total 41 485 singleton pregnancies 1997–2014, which 541 were identified exposure 40 944 unexposed. Methods By linkage national health population register data, we...
Abstract Objective To quantify temporal trends and regional variation in severe maternal morbidity (SMM) Sweden. Design Cohort study. Population Live birth stillbirth deliveries Sweden, 1999–2019. Methods Types subtypes of SMM were identified, based on a standard list (modified for Swedish clinical setting after considering the frequency validity each indicator) using diagnoses procedure codes, among all at ≥22 weeks gestation (including complications within 42 days delivery). Contrasts...
Abstract Background It is unclear whether sarcoidosis, a multisystem inflammatory disease, associated with adverse pregnancy outcomes. We aimed to assess the risk of maternal and infant outcomes in sarcoidosis pregnancies, focused on first births. Methods Using population-based cohort study design Swedish national registers (2002–2013), we identified 182 singleton pregnancies Medical Birth Register at least two ICD-coded visits prior National Patient Register. Modified Poisson regression...
To evaluate pregnancy outcomes in relation to antirheumatic treatment before and during pregnancy, as a proxy of disease severity pregnant women with psoriatic arthritis (PsA), compared those without PsA.Our study focused on Swedish nationwide registry-based cohort that included 921 PsA pregnancies 9,210 non-PsA occurring between 2007 2017 (matched 1:10 based maternal age, year delivery, parity). We estimated adjusted odds ratios (ORs) overall, 95% confidence intervals (95% CIs), stratified...
<b>Background:</b> It is unclear whether sarcoidosis, a multisystem inflammatory disease, associated with adverse pregnancy outcomes. <b>Aim:</b> To assess the risk of maternal and fetal outcomes in sarcoidosis pregnancies. <b>Methods:</b> Using population-based cohort study design Swedish national registers (2002-2013), we identified 764 singleton pregnancies (258 first pregnancies) Medical Birth Register at least one ICD-coded visit prior to National Patient Register. Modified Poisson...